Neil Flomenberg, MD, is an accomplished researcher whose work has been supported by grants from the National Cancer Institute, Dr. Flomenberg's research interests center on ways to make allogeneic transplants (using a donor, rather than the patient's own stem cells) safer. In addition, he is also working to try to prevent deadly graft-versus-host-disease (GVHD), the bane of marrow and peripheral blood progenitor cell transplants, and hopes to find ways to increase immune system recovery after allogeneic transplant. These efforts have opened up opportunities for successful transplantation of patients lacking a well matched donor.

A recipient of numerous teaching and research awards, Dr. Flomenberg received the prestigious Service to Mankind Award from the regional Leukemia & Lymphoma Society in 2006 and in 2003, he was named the Leukemia & Lymphoma Society's Man of the Year for Eastern Pennsylvania. In 2006, he was also recognized as that year's outstanding alumnus by the Pennsylvania State University Eberly College of Science. He has published widely in such journals as Blood and the Proceedings of the National Academy of Sciences, and is a member of such organizations as the American Society for Hematology, the American Society for Blood and Marrow Transplantation and the Transplantation Society, and the Foundation for Accreditation of Cellular Therapy. He received the Gratz Award from Jefferson for research efforts most likely to influence clinical practice.

Dr. Flomenberg received a Bachelor of Science degree from Penn State University in 1974, and earned a doctor of medicine degree from Jefferson Medical College in 1976 through a joint Jefferson-Penn State accelerated medical degree program.

Demetrius Bagley, MD, major interests and expertise are in urologic endoscopy, laser therapy and the treatment of calculi and endoscopic treatment of tumors of the ureter and renal collecting system. He has been invited to speak internationally on his experience in these fields.

Dr. Bagley is a member of the major urologic and endoscopic organizations. Recently, he has been named Editor-in-Chief of Diagnostic and Therapeutic Endoscopy online Journal. He is an Associate Editor of Journal of Endourology and Associate Editor of Surgical Endoscopy-Ultrasound and Interventional Techniques. Dr. Bagley is the author of three books on urologic endoscopy and has authored over 300 original papers and chapters.

Dr. Bagley has been cited among the Best Doctors In America for stone treatment and ureteroscopy. He has been cited annually in Philadelphia Magazine as one of the Top Doctors in Philadelphia. Dr. Bagley is an associate member of the Kimmel Cancer Center of Jefferson.

Clinical interests include the treatment of urinary calculi, tumors of the ureter and kidney, ureteral obstruction and difficult endoscopic problems. Dr. Bagley is an internationally recognized expert in these areas of endourology.

Paul J. DiMuzio, MD, FACS,  is the William M. Measey Professor of Surgery at Jefferson Medical College of Thomas Jefferson University and Thomas Jefferson University Hospital in Philadelphia.  Dr. DiMuzio currently serves as the Program Director for Fellowships in Vascular Surgery, the Director for the Division of Vascular Surgery, the Director of the Jefferson Aortic Center, an Associate Professor of Surgery and an Associate Professor of Radiology.  In 2008, Dr. DiMuzio was awarded Thomas Jefferson University’s Dean’s Faculty Mentoring Award and was named to Philadelphia Magazine’s “Top Doctors” list.

The field of vascular surgery has undergone significant changes in the last decade, mostly involving the institution of minimally invasive endovascular surgical techniques.  Dr. DiMuzio leads the members of the Division of Vascular and Endovascular Surgery at Jefferson, who have incorporated these techniques into their practice, including carotid artery stenting, endovascular aortic aneurysm repair and many of the various ways to treat peripheral vascular disease through a percutaneous approach. 

Dr. DiMuzio received his BA in Natural Sciences from Johns Hopkins University and his medical degree from the University of Pennsylvania School of Medicine.  He completed his residency in general surgery at Thomas Jefferson University Hospital and did his fellowship training in vascular surgery at the University of California, San Francisco.

Cataldo Doria, MD, PhD, FACS, is Associate Professor of Surgery and Director of the Division of Transplantation at Jefferson Medical College of Thomas Jefferson University. Dr. Doria is a multi-organ transplant surgeon with extensive expertise in cadaveric and living related liver and kidney transplant, pancreas transplant, small-bowel transplant as well as liver and pancreatic resection and surgery of the bile duct. Dr. Doria has personally performed more than 450 organ transplants, and authored over 170 publications. Dr. Doria came to Jefferson from the Mediterranean Institute for Transplantation and Advanced Specialized Therapies (IsMeTT- UPMC Italy) – a partnership between the University of Pittsburgh Medical Center and the Italian National Government – where he served as Chief of Abdominal Organ Transplant. He also served as Assistant Professor of Surgery at the University of Pittsburgh School of Medicine, and at the Thomas E. Starzl Transplantation Institute, Children’s Hospital of Pittsburgh, and the U.S. Department of Veterans Affairs Medical Center, Pittsburgh. His research interests include issues in liver transplantation, use of artificial liver, and liver resection for cancer treatment.

Dr. Doria is a member of numerous professional and scientific societies, including the:

• Academy of Surgical Research
• American College of Surgeons
• American Hepato Pancreato Biliary Association
• American Society of Transplant Surgeons
• American Society of Transplantation
• Association for Academic Surgery
• Cell Transplant Society
• European Society for Organ Transplantation
• International College of Surgeons (U.S. Section)
• International Liver Transplantation Society
• Italian Association Professors of Surgery
• Italian Society of Surgery
• Society for Surgery of the Alimentary Tract
• Society for the Advancement of Blood Management
• Society of Critical Care Medicine
• Society of University Surgeons
• Transplantation Society

 

He completed a research fellowship in small bowel transplantation at the University of Pittsburgh Transplantation Institute and a clinical fellowship in multi-organ transplantation at the Thomas E. Starzl Transplantation Institute at the University of Pittsburgh. He earned his PhD in Immunology in 2006.

The Jefferson Center for Minimally Invasive Cranial Base Surgery and Endoscopic Neurosurgery is a comprehensive center in the Philadelphia area where surgeons are able to remove skull-based tumors through nose and nasal sinuses instead of the traditional, more invasive surgery which required opening up the brain and skull. Marc Rosen, MD, assistant professor of Otolaryngology-Head and Neck Surgery, and James Evans, MD, assistant professor of Neurosurgery, both of Jefferson Medical College of Thomas Jefferson University serve as the center’s co-directors. Drs. Evans and Rosen have been working together for several years and have performed at least 150 of these endoscopic procedures to date.

Dr Andrews is recognized as a world leader in radiosurgery and established the first Radiosurgery Program in the Delaware Valley in 1991. He has lectured throughout the world as an invited speaker on radiosurgery topics and is noted for his pioneering techniques in stereotactic radiotherapy.

Drawing from his background in molecular biology, Dr. Andrews was the first physician at Thomas Jefferson University and in the Delaware Valley to participate in a prospective randomized trial involving gene therapy for the treatment of glioma, which closed in 1999. Dr. Andrews currently serves as Co-Principal Investigator of a unique FDA-approved antisense DNA protocol designed for the treatment of glioma and has thus far successfully treated 12 patients. With this Phase I study still open, he has submitted four additional Phase I through Phase III proposals to the FDA for approval based on the early promising results in the Phase I trial.

Dr. Andrews trained at the New York Hospital-Cornell Medical Center and completed a one year fellowship in Neuro-oncology at the Memorial Sloan-Kettering Cancer Center. At the inception of his academic career, he received a prestigious Physician Scientist Award conferred by the National Cancer Institute to pursue basic research devoted to the molecular biology of gliomas for a 5 year period. His mentor was Dr. Carlo Croce, a member of the National Academy of Science and one of the leading cancer researches in America today.

Paul J. Mather, MD, is the director of the Advanced Heart Failure and Cardiac Transplant Center at the Jefferson Heart Institute of Thomas Jefferson University Hospitals in Philadelphia. He is also associate professor of Medicine at Jefferson Medical College of Thomas Jefferson University.

Dr. Mather received a bachelor of arts degree in 1984 from the University of Pennsylvania, and a doctor of medicine degree in 1988 from Temple University School of Medicine. He completed an internship and residency in internal medicine at Temple University Hospital in 1991 and remained there to complete a fellowship in cardiovascular diseases in 1994.

Dr. Mather’s clinical interests include congestive heart failure (CHF), echocardiography and cardiac transplantation. His research interests encompass heart failure outcomes analyses, left ventricular assist devices, improving the efficiency of cardiac function with pacemakers and heart and lung transplantation. Dr. Mather has been a frequent presenter at local grand rounds as well as at national meetings.

His professional memberships include the American College of Cardiology, American Society of Echocardiography and the International Society of Heart and Lung Transplantation where he is on the Heart Failure Council as well as the steering committee of the Mechanical Circulatory Support Database Committee. Dr. Mather is also a member of the Heart Failure Society of America, for which he was on the Care Standards Committee, the American Society of Transplantation and Alpha Omega Alpha (AOA) Medical Honor Society as an alumni honoree.

Dr. Mather is also a member of the Congestive Heart Failure Task Force of the Pennsylvania Chapter of the American College of Cardiology. He is the author or co-author of numerous articles in professional journals and book chapters on heart failure, echocardiography and related topics.

The Jefferson Center for Minimally Invasive Cranial Base Surgery and Endoscopic Neurosurgery is a comprehensive center in the Philadelphia area where surgeons are able to remove skull-based tumors through nose and nasal sinuses instead of the traditional, more invasive surgery which required opening up the brain and skull. Marc Rosen, MD, assistant professor of Otolaryngology-Head and Neck Surgery, and James Evans, MD, assistant professor of Neurosurgery, both of Jefferson Medical College of Thomas Jefferson University, serve as the center’s co-directors. Drs. Evans and Rosen have been working together for several years and have performed at least 150 of these endoscopic procedures to date.

Dr. Rosenwasser, a cerebrovascular surgeon, is chair of the Department of Neurosurgery at Jefferson Medical College of Thomas Jefferson University and Thomas Jefferson University Hospitals in Philadelphia. Dr. Rosenwasser is world renowned for his surgical expertise in both preventing and treating life-threatening brain aneurysms. Dr. Rosenwasser does more such operations annually than any other surgeon in the country. He most recently has helped pioneer the use of a soft, flexible stent made of a non-metallic polymer – the first of its kind in the world to be used for brain aneurysms that could not be readily treated surgically. The type of stent, called an intracranial stent, was developed specifically for blood vessels in the brain and for cerebral aneurysms.

Takami Sato, MD, PhD, is a Professor of Medical Oncology at Jefferson Medical College of Thomas Jefferson University and Thomas Jefferson University Hospitals in Philadelphia. Dr. Sato currently serves as the Director of the Metastatic Uveal Melanoma Program in the Department of Medical Oncology at Thomas Jefferson University Hospitals, the Co-leader of the Immunology Program at the Kimmel Cancer Center at Jefferson and as the Associate Director for International Affairs at the Kimmel Cancer Center at Jefferson. Dr. Sato has been named to Americas Top Oncologists (2007) and Best Doctors In America (2004-2008).

Dr. Sato has led multiple clinical trials and has been awarded large research grants. Dr. Sato serves as Chief Editor to What’s New in Oncology as well as on the editorial board of the Medical Science Monitor and as a reviewer for five scientific journals; International Journal of Cancer, Medical Science Monitor, Cancer Immunology and Immunotherapy, Cancer Research and Cancer.

Dr. Sato received his medical degree at Jichi Medical School in Japan and went on to his post graduate training in Internal Medicine and Pediatrics at Oita Prefectural Mie Hospital. He completed his fellowship training in Pediatric Oncology at Jichi Medical School. Dr. Sato received his PhD in 1997 from Jichi Medical School in Japan.

Dr. Ashwini is an Assistant Professor of Neurosurgery, specializing in neurostimulation surgery. Dr. Sharan provides unique expertise in deep brain stimulation for Parkinson’s disease, essential tremor, and dystonia. His other areas of expertise include intrathecal pump implantation for spasticity, cortical and spinal cord stimulation for chronic pain disorders, and vagal nerve stimulation for epilepsy.

His sub-specialization in spinal neurosurgery complements his interest in spinal cord injury research, degenerative spinal diseases with and without complex spinal instrumentation, minimally invasive approaches to spinal disorders, reconstructive spinal surgery, spine and spinal tumors, osteomyelitis and epidural infections, among other services. Dr. Sharan further collaborates with the Jefferson Epilepsy Center on providing surgical treatment for Epilepsy.

Stephen D. Silberstein, MD, FACP, is Professor of Neurology at Jefferson Medical College of Thomas Jefferson University. Dr. Silberstein received his doctor of medicine degree in 1967 from the University of Pennsylvania, where he also did his internship and residency. He trained and did medical research at the National Institutes of Mental Health. Dr. Silberstein has done extensive research and investigational drug studies in his field, focusing primarily on the treatment of acute migraine headache and the role of sex hormones in menstrual migraine. There are nearly 200 peer-reviewed articles, book chapters and abstracts resulting from his research. Dr. Silberstein currently serves on the editorial boards of several professional publications including Headache, Topics in Pain Management, and Cephalalagia. He is also a past president and vice president of the Philadelphia Neurological Society.

Scott C. Silvestry, MD, FACS, Surgical Director of the Heart Transplant Program, specializes in valvular heart disease and heart failure and has extensive knowledge of leading-edge pharmaceuticals for treatment of heart failure. He earned his medical degree from the University of Pennsylvania School of Medicine and completed his surgery training and a fellowship in cardiovascular and thoracic surgery at Duke University Medical Center. Dr. Silvestry is a recipient of a NIH-National Research Service Award.

Michael R. Sperling, MD, is the Baldwin Keyes Professor of Neurology in the Department of Neurology at Thomas Jefferson University. He is the Director of the Jefferson Comprehensive Epilepsy Center and the Clinical Neurophysiology fellowship at Thomas Jefferson University Hospitals, as well as the Director of the Clinical Neurophysiology Laboratories at Thomas Jefferson University and Wills Eye Hospitals. Dr. Sperling was also the Director of the Comprehensive Epilepsy Center (1995 – 1997), the Epilepsy Monitoring Unit (1985 – 1997), and the Neurophysiology Laboratory (1985 – 1997) at Graduate Hospital.

Dr. Sperling received his medical degree from Temple University School of Medicine in 1978, completed an internship and a neurology residency at Mount Sinai Hospital in 1979 and 1982, respectively, and completed a fellowship in Epilepsy and Clinical Neurophysiology at UCLA School of Medicine in 1984. Since then he has held faculty positions at UCLA, University of Pennsylvania, Temple University, and Jefferson Medical College. Dr. Sperling is board certified in Neurology by the American Board of Psychology and Neurology and is also certified in Clinical Neurophysiology by the American Board of Psychiatry and Neurology and the American Board of Clinical Neurophysiology.

Dr. Sperling is on the Editorial Board of Epilepsy Research and is a reviewer for numerous medical journals. He has been invited to speak at many international meetings and frequently participates in national lectures. He is a member of many professional organizations, including the American Epilepsy Society, and was President of the American Clinical Neurophysiology Society and the Philadelphia Neurological Society. He is a board member of the Epilepsy Foundation of Eastern Pennsylvania and was chair of the Professional Advisory Board. He has published almost 300 peer-reviewed articles, book chapters and abstracts in both international and national medical journals, including Epilepsia, Neurology, Journal of the American Medical Associations, and Annals of Neurology. Dr. Sperling has been awarded numerous grants and is actively involved in the study of epilepsy surgery, genetic influences on human epilepsy, and drug therapy.

Charles J. Yeo, MD, FACS, is the Samuel D. Gross Professor and Chair of the Department of Surgery at Jefferson Medical College of Thomas Jefferson University. His primary interests and research are hepatopancreaticobiliary surgery—the evaluation of patients with pancreatic and related cancer, and the management of patients with unusual pancreatic neoplasms, as well as acute or chronic pancreatitis. He has personally performed over 835 Whipple procedures, and has treated over 1200 patients with pancreatic and related cancer.

Dr. Yeo is the co-editor of the highly successful five-volume encyclopedic Shackelford’s Surgery of the Alimentary Tract, 5th Edition, published in 2002, and the editor-in-chief of the 6th edition, in 2007. He currently serves on the editorial boards of two journals (Langenbeck’s Archives of Surgery and Surgery), and he is the associate editor of Advances in Surgery and the Journal of Gastrointestinal Surgery. He has authored over 350 peer reviewed scientific papers, numerous abstracts, and over 85 book chapters. Dr. Yeo travels nationally and internationally teaching and lecturing on the treatment of benign and malignant pancreatic diseases.